Presentations

Documents

Order by : Name | Date | Hits | [ Ascendant ]

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened pheno.. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened pheno..

hot!
Date added: 12/31/2018
Date modified: 12/31/2018
Filesize: 256 Bytes
Downloads: 186

"Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD"

Poster presentation given by CNR at the 24th National Congress of Digestive Diseases: Italian Federation of Societies of Digestive Diseases (FISMAD), Rome, Italy, 15th March 2018

Diagnostic tools to assess fibrosis in practice and clinical trials Diagnostic tools to assess fibrosis in practice and clinical trials

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 185

Oral presentation given by UMC at Digestive Disease Week (DDW), Washington DC, USA, 2nd - 5th June 2018

Study design to validate biomarkers of therapeutic response in NASH due to cirrhosis Study design to validate biomarkers of therapeutic response in NASH due to cirrhosis

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 177

Oral presentation given by UMC at the 3rd International Workshop on NASH Biomarkers, Washington DC, USA, 18th - 19th May 2018

Mitochondra and progression of NAFLD Mitochondra and progression of NAFLD

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 175

Oral presentation given by CNR at the  27th Annual Meeting of the Italian Society for the study of Diabetes (SID), Rimini, Italy, 19th May 2018

Metabolomics Metabolomics

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 175

Oral presentation given by CNR at the International Symposium: “Biomarkers for Personalized Hepatology”, Pisa, Italy, 30th May 2018

The burden of fatty liver disease in an aging population The burden of fatty liver disease in an aging population

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 173

Oral presentation given by UNITO at the 52nd Annual Scientific Meeting of the European Society for Clinical Investigation (ESCI 2018), Barcelona, Spain, 31st May 2018

Which patients will we be treating in 2020 and how will pharmacotherapy be tailored? Which patients will we be treating in 2020 and how will pharmacotherapy be tailored?

hot!
Date added: 01/19/2019
Date modified: 01/19/2019
Filesize: 4.98 MB
Downloads: 171

Oral presentation given by UNITO at the EASL International Liver Congress, Paris, France, 11th - 15th April 2018

Novel Biomarkers and Technologies to Assess Fibrosis and Remodeling in NASH Novel Biomarkers and Technologies to Assess Fibrosis and Remodeling in NASH

hot!
Date added: 04/11/2019
Date modified: 04/11/2019
Filesize: 256 Bytes
Downloads: 146

Oral presentation given by UMC at AASLD/EASL NAFLD Endpoints Conference, Alexandria, VA, USA, 30th June 2018

Lipidomics workflows in clinical research – practical considerations Lipidomics workflows in clinical research – practical considerations

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 143

Oral presentation given by ORU at the 42nd International Symposium on Capillary Chromatography (ISCC), Riva del Garda, Italy, 16th May 2018

Elucidation of metabolic changes in non-alcoholic fatty liver disease and the role of environ... Elucidation of metabolic changes in non-alcoholic fatty liver disease and the role of environ...

hot!
Date added: 12/31/2018
Date modified: 12/31/2018
Filesize: 2.03 MB
Downloads: 136

"Elucidation of metabolic changes in non-alcoholic fatty liver disease and the role of environmental, nutritional and genetic factors"

Oral presentation given by ORU at Analytica, Munich, Germany, 10th - 12th April 2018